Bioxyne |
High $0.02 |
Low $0.02 |
Trades 6 |
Turnover $595 |
Volume 31,196 |
| 30 June 2023 at 3:10pm | ||||
|
Market Cap (13-Nov) $213,879,616 (1,730th) |
Close (30-Jun) $0.020 |
Volume (30-Jun) 31,196 |
Shortsold (6-Jul) 50,000 (0.02%) (574th) |
|
52w High $1.20 |
52w Low $0.350 |
P/E 19.69 |
EPS 0.04 |
Explanatory Note to the 2021 Annual Report
BXN released this announcement to the ASX on 30 September 2021, 16:36. The announcement is marked as price sensitive, and is 1 page(s) in length and 97.05kb in size.
You can view all announcements from BXN and see how they appear on a price chart on the announcements page.
At the date of this announcement, BXN was 0.000% short sold according to ASIC data. It was ranked the 595th most shorted stock on the ASX. It is now ranked as the 574th most shorted stock on the ASX with 0.022% of total shares short sold as of the latest reported data (06 July 2026).
| Other Recent Announcements from BXN | |
|---|---|
| Bioxyne Launches BLS Clinics - Online Healthcare | 13 June 2023, 9:05 |
| Becoming a substantial holder | 8 June 2023, 16:36 |
| Becoming a substantial holder | 31 May 2023, 17:30 |
| Explanatory Note to the 2021 Annual Report | 30 September 2021, 16:36 |
| Preliminary Final Report | 31 August 2021, 11:04 |
| Quarterly Activities/Appendix 4C Cash Flow Report | 22 July 2021, 9:48 |
| Appendix 4C - quarterly | 30 April 2021, 9:45 |
If you were already registered, log in here.